You just read:

Napo Pharmaceuticals Launches Mytesi (crofelemer) as the Only FDA-Approved Treatment for Relief of Noninfectious Diarrhea in HIV+ Patients

News provided by

Napo Pharmaceuticals, Inc.

Oct 13, 2016, 08:00 ET